ISO 5840-1:2021

Overview

ISO 5840-1:2021 - "Cardiovascular implants - Cardiac valve prostheses - Part 1: General requirements" establishes the general, risk‑based framework for the development, verification and validation of heart valve substitutes intended for human implantation. It covers design inputs and outputs, operational conditions, testing strategies, packaging, labelling and the documentation needed to demonstrate safety and performance. ISO 5840-1 sets out terms and principles that are referenced by the more device‑specific parts of the series (ISO 5840-2 and ISO 5840-3).

Key technical topics and requirements

• Risk management driven design: Selection of qualification tests and methods is derived from a formal risk assessment; ISO 5840-1 outlines the approach to verify/validate design and manufacture.
• Design inputs and outputs: Operational and performance specifications, implant procedure considerations, and design transfer (manufacturing verification/validation).
• In vitro testing and analysis: Material property assessment, hydrodynamic performance, structural performance, simulated use, device MRI compatibility, and human factors/usability evaluation.
• Biological and haemocompatibility concerns: Assessment of thrombogenic and haemolytic potential and relevant biological testing.
• Preclinical and clinical evaluation: Guidance on preclinical in vivo studies and clinical investigations, including recommended endpoints and reporting.
• Durability and fatigue: Guidance and normative requirements for durability testing, fatigue assessment and long‑term mechanical integrity.
• Packaging, labelling and sterilization: Normative annexes define packaging, labelling, instructions for use, training and sterilization considerations specific to implanted heart valve systems.
• Terminology and scope limits: Defines terms used across the ISO 5840 series and explicitly excludes (but partially addresses) homografts, tissue‑engineered valves, and valves for circulatory support devices.

Practical applications - who uses this standard

• Medical device manufacturers - to structure R&D, verification, validation and dossier preparation for regulatory submissions.
• Design and quality engineers - to define design inputs/outputs, test plans and manufacturing validation.
• Preclinical and test laboratories - to select and execute hydrodynamic, mechanical, corrosion and biocompatibility testing.
• Regulatory affairs professionals - to align clinical and preclinical evidence with internationally accepted expectations.
• Clinicians and hospitals - to understand labelling, sizing guidance, and operational specifications for implantation.

Related standards

• ISO 5840-2 - Surgically implanted heart valve substitutes (device‑specific requirements).
• ISO 5840-3 - Heart valve substitutes implanted by transcatheter techniques (device‑specific requirements).

ISO 5840-1 is essential for ensuring cardiovascular implants meet internationally harmonized expectations for safety, performance, testing and documentation. Keywords: ISO 5840-1, cardiac valve prostheses, heart valve substitutes, cardiovascular implants, design verification, risk management, hydrodynamic performance, durability testing, biocompatibility, preclinical evaluation.